Literature DB >> 15108591

[Methyldopa in therapy of hypertension in pregnant women].

Agnieszka Seremak-Mrozikiewicz1, Krzysztof Drews.   

Abstract

Both chronic hypertensive disorders in pregnancy and pregnancy-induced hypertension are the main causes of morbidity and mortality of mothers and fetuses. The great significance in the prevention of serious complications of them has properly pharmacology treatment. One of the most early and the most often used drug is Methyldopa--a drug from the group acting via central nervous system, causing the depression in the cardio-vascular system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15108591

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  1 in total

1.  Combined Effects of Methyldopa and Flavonoids on the Expression of Selected Factors Related to Inflammatory Processes and Vascular Diseases in Human Placenta Cells-An In Vitro Study.

Authors:  Anna Bogacz; Przemysław Ł Mikołajczak; Marlena Wolek; Aleksandra Górska; Michał Szulc; Marcin Ożarowski; Radosław Kujawski; Bogusław Czerny; Hubert Wolski; Tomasz M Karpiński; Agnieszka Seremak-Mrozikiewicz
Journal:  Molecules       Date:  2021-02-26       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.